Computational Chemistry Intern - 2026 jobs in United States
cer-icon
Apply on Employer Site
company-logo

Genesis Molecular AI · 4 months ago

Computational Chemistry Intern - 2026

positionBurlingame, CA
timeInternship
remoteOnsite
seniorityIntern
workcardStart in 2026 Spring

Genesis Molecular AI is bringing together a world-class computational team to build out the industry's fastest and most accurate small molecule property predictions. They are seeking early career scientists skilled in developing and applying computational chemistry and physics methodologies to drive forward their drug discovery programs.

Artificial Intelligence (AI)BiotechnologyInformation Technology
check
H1B Sponsor Likelynote

Responsibilities

Develop and refine advanced computational chemistry and physics methodologies to help solve pressing challenges in our internal drug discovery programs
Collaborate with our machine learning team on hybrid physics/ML methods for predicting structure, potency, and other properties relevant to drug discovery
Work closely with our computer-aided drug discovery scientists and medicinal chemists to develop, benchmark, and deploy improvements to our drug discovery platform as it is applied to our internal and partnered drug discovery programs

Qualification

Computational ChemistryPhysics MethodologiesMachine LearningPython ProgrammingCollaboration

Required

A graduate student with a proven track record of applying or developing computational chemistry and physics methods
Passionate about building methods to solve real problems
A skilled programmer, preferably in Python, such that you can quickly implement your research ideas and analyze their performance

Benefits

Medical, dental, and vision insurance
401(k) program

Company

Genesis Molecular AI

twittertwitter
company-logo
Genesis Therapeutics unifies AI and biotech to accelerate the discovery of new medicines.
dateFounded in 2019
location
South San Francisco, California, USA
people-size51-200 employees
web-link
https://genesis.ml/

H1B Sponsorship

Genesis Molecular AI has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (3)
2024 (1)
2023 (1)
2022 (1)

Funding

Current Stage
Growth Stage
Total Funding
$256.1M
Key Investors
Andreessen HorowitzRock Springs Capital
2023-08-21Series B· $200M
2020-12-02Series A· $52M
2020-04-01Series Unknown

Leadership Team

leader-logo
Evan Feinberg
Founder and CEO
linkedin
leader-logo
Aleksandra Faust
Chief AI Officer
linkedin

Recent News

Genetic Engineering News
NeurIPS 2025: Biology’s Transformer Moment
2025-12-10
Business Wire
Genesis Molecular AI Appoints Sergey Edunov as Senior Vice President of Foundation Models, Further Strengthening Leadership in Machine Learning
2025-12-02
MIT Technology Review
What’s next for AlphaFold: A conversation with a Google DeepMind Nobel laureate
2025-11-27
Company data provided by crunchbase